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What is Medicaid HEDIS?
HEDIS (Health Plan Employer Data and Information Set) is the
performance measurement system for health plans developed by the
National Committee for Quality Assurance (NCQA). The NCQA is
an organization which accredits health plans as well as other types
of health care organizations. The number of NCQA accredited
managed care plans now exceeds 330, covering three quarters of all
HMO enrollees or roughly 45 million Americans. HEDIS data is
collected by more than 90 percent of all health plans. Medicaid
HEDIS is an adaptation of HEDIS 2.0/2.5 for use by health plans
with Medicaid managed care programs. In 1997, Medicaid HEDJS
was incorporated into HEDIS 3.0. Therefore, QUEST plans will
report their HEDIS data for the 1998 fiscal year in HEDIS 3.0
format.
What is measured in Medicaid HEDIS?
Health plan performance related to the following seven (7) areas
is measured:
• Membership;
• Utilization;
• Quality of Care;
• Access to Care;
• General Plan Management;
• Financial Performance; and
• Satisfaction with Care.
Health plan performance for membership, utilization, quality of
care, and access measures are reported as tables. Membership and
utilization measures relate to all members. Generally, quality of care
measures apply to members continuously enrolled for 12 months
with a maximum lapse in coverage of 30 days. Access to care
measurements relate to the availability of services. Most general
plan management measures require health plans to describe specific
services.
Department of Human Services
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What measures are the QUEST plans required to report?
The QUEST medical plans are required to report measures related
to membership, utilization, ciuality of care, access to care, and
general plan management. Since all QUEST plans are required to
submit financial statements, and an annual customer satisfaction
survey is performed by the Med-QUEST Division (MQD), plans are
not required to report financial performance and satisfaction with
care as part of their Medicaid HEDIS report.
Why is the DHS requiring QUEST plans to report Medicaid
HEDIS data?
Medicaid HEDIS has standardized data collecting and reporting
requirements and its measures are clearly defined. It allows the
evaluation of a plan’s performance overtime, identification of areas
which should be improved, quantitative measurement of strategies
a plan uses to improve outcomes, and comparison of similar
elements across plans.
What should be considered in reviewing the QUEST Medicaid
HEDIS report?
The data presented is an aggregate ofdata submitted by individual
QUEST medical plans. Since Medicaid HEDIS specifications allow
for data collection using various specified methodologies, the
QUEST plans may select alternative methodologies to report the
same measure. Therefore, differences in data sources and data
collecting methodologies may affect the validity of the aggregate
data presented. Additionally, while the QUEST plans reviewed
their individual reports and verified the data prior to submission, the
Department does not audit each plan’s data (NCQA does not require
it either). However, the Department executes a protocol to examine
the contents for accuracy and consistency.
Medicaid i-lEDIS specifications require 12 continuous months of
enrollment with one lapse in coverage not to exceed 30 days for most
of the quality of care measures. Therefore, the quality of care
measures do not reflect the experience of a plan’s total membership,
only that of members who met the definition of “continuously
enrolled.”
Medicaid HED1S cautions that data from health plans with “small
numbers” for a measure may be of questionable statistical validity.
What are the Medicaid HEDIS measures being reported?
The QUEST plans reported a total of 37 mandatory measures. The
collection of these measures is available from the Med-QUEST
Division. This report will focus on the following twelve (12)
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measures which are key to assessing QUEST’s performance in
providing quality care:
• Membership by Age and Sex;
• Childhood Immunization;
• Cervical Cancer Screening;
• Cesarean Section;
• Diabetic Retinal Exam;
• Inpatient Acute Hospital Care;
• Emergency Room Visits;
• Live Births;
• Mental Health and Chemical Dependency Services;
• Outpatient Drug Utilization;
• Low Birthweight; and
• Care Access: Utilization of Primary Care Providers by Children.
In addition, a description of how managed care is being provided
by the QUEST medical plans is presented. The description includes
four key programs in the delivery of managed care services:
• Case Management;
• Utilization Management;
• New Member Orientation/Education; and
• Standards for Waiting Times.
Overall, this report focuses primarily on data submitted by QUEST
medical plans for fiscal 1997. However, Medicaid HEDIS data for
fiscal 1996 is included, when available, to note changes in QUEST
performance over time. HEDIS measures were reported in fiscal
1995 but have been excluded for comparison in most instances due
to the following reasons:
• QUEST began on August 1, 1994. Therefore, fiscal 1995 for
QUEST was only 11 months in duration;
• In the initial months of QUEST, there were many plan changes
and significant confusion among providers as to which plan
should be receiving and reporting a patient’s encounter data;
• Medicaid HEDIS measures were not available. Hence, the plans
reported a combination of HEDIS 2.0/2.5 and specific state
measures, which in many cases, were not directly comparable
with Medicaid HEDIS measures.
Membership by Age and Sex
Why is this important?
This measure answers general questions about the people who are
receiving their health care services through QUEST.
What was measured?
The total number of unduplicated QUEST enrollees by age and
sex, enrolled during any part of the report year from July 1, 1996 to
June 30, 1997 was recorded.
How did QUEST perform?
Enrollment in QUEST decreased from an average monthly mem
bership of 155,420 in fiscal 1996 to 134,830 in fiscal 1997. The
QUEST population in fiscal 1997 was also younger. The mean age
of QUEST members dropped to 20.1 years in fiscal 1997 from 21.3
years in fiscal 1996. QUEST members remain predominantly chil
dren and adult females. Approximately 56 percent of total member
ship were children under 20 years of age.
Chart I
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The age and sex distribution of a population for a given fiscal year
can be summarized graphically by a “population pyramid.” A
population pyramid displays the distribution of male and female
members in different age-groups. Chart I shows QUEST’s popula
tion structure in fiscal 1997, as compared to Hawaii’s resident
population in 1995. The QUEST population displays a skewed,
classic “pyramid”, with a large proportion of younger people, fewer
middle-aged people, and far fewer elderly people. There is also a
disproportionate number of middle-aged women.
In contrast, the Hawaii resident population structure resembled a
bulging “pillar.” This is a more mature population, with proportion
ately fewer young people (ages 0-24) contributing to the total. The
middle-aged group (ages 25-54) is the dominant segment of this
population structure while the near-elderly (ages 55-64) and elderly
(ages 65 and over) appear rather significant before tapering off. The
average age of Hawaii’s resident population in 1995 was 34.5 years
of age. Additionally, there were 102 males per 100 females in the
same population. In comparison, there were only 95.6 males per 100
females in the QUEST population in fiscal 1997.
Childhood Immunization
Why is this important?
Immunization in the first two years of life is accepted as one of the
most effective public health measures in preventing serious illnesses
such as whooping cough, polio, measles, and hepatitis B. Unfortu
nately, studies have shown that low-income children are less likely
to receive timely and adequate immunizations. In 1990, the Centers
for Disease Control (CDC) reported that less than 50% of low-
income inner city children were fully immunized by age two.
What was measured?
The childhood immunization rate is the percentage of QUEST
two-year olds who were enrolled in one plan for 12 months, and who
had received appropriate immunizations by their second birthdays
(A break in enrollment not to exceed 30 days was allowed).
How did QUEST perform?
QUEST did very well compared to the previous fiscal year and to
rates reported in other studies. The Childhood Immunization Rate
improved to 77.4 percent in fiscal 1997 from 62.5% in fiscal 1996.
At this rate of improvement, QUEST should realize the “Healthy
People 2000” goal of 90 percent Childhood Immunization Rate.
Recently, the NCQA released its first annual report on HEDIS
measures, “The State of Managed Care Quality.” This report col
lected information, voluntarily submitted by over 330 health plans
throughout the United States, which participated in the NCQA’s
accreditation program. The NCQA reported that the national aver
age rate of children who had received 4 DTPIDTaP (diptheria
tetanus-pertussis), 3 polio (OPV/IPV), 1 MMR (measles-mumps-
rubella), 1 Hib (H influenza type b), and 2 HepB (Hepatitis B) was
65.3% for the health plans which submitted data. Retrospective
studies done in Hawaii on children entering kindergarten have
shown that between 58-63% received the basic series by age 2.
Chart 2
Childhood Immunization Rates
Source: Med-QUEST and NCQA.
Cervical Cancer Screening
Why is this important?
Nationally, more than 13,000 new cases of cervical cancer are
diagnosed each year, and 4,800 women die of the disease annually.
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Additionally, the rate of cervical cancer is typically higher among
poor women and they are more likely to be diagnosed when the
cancer is in advanced stages. Fortunately, cervical cancer is curable
if detected early by regular check-ups and the use of the Papanico
laou (Pap) smear test. Thus, for Medicaid women, cervical cancer
screening is very important and saves lives.
What was measured?
The cervical cancer screening rate is the percentage of women
aged 16 to 64, enrolled in a medical plan for 12 months, who had at
least one Pap smear during the past three years.
How did QUEST perform?
The QUEST medical plans did not report this measure in fiscal
1996. In fiscal 1995, the reported rate was 33.8 percent. This rate was
for the first eleven (11) months of QUEST program and was reported
by four (4) of the five (5) plans. Another shortcoming of the 1995
QUEST data was the plans did not have three years worth of data as
required by the measure.
In fiscal 1997, the QUEST screening rate reported was 70.2
percent (women aged 16 to 64). This screening rate is compatible
with a recently released NCQA study which reported a 70.4 percent
national average for women aged 21 to 64 in participating health
plans. The “Healthy People 2000” goal is to have 85 percent of all
women receive a Pap smear every one to three years.
Chart 3
Cesarean Section
Why is this important?
Cesarean (C)-sections are among the most frequent surgical
procedures performed in the United States and both mother and
neonate have a greater chance of complications than with vaginal
birth. A C-section is normally unnecessary if vaginal delivery of the
baby does not pose a serious health risk to the infant or mother.
Hospital and physician services associated with C-section deliver
ies are more costly than vaginal deliveries. Therefore, the rate of C-
section deliveries is an indicator of appropriate clinical management
and quality of care.
What was measured?
The C-section rate is the percentage of total QUEST deliveries
resulting in live newborns which were C-section delivered in fiscal
1997.
How did QUEST perform?
The QUEST plans performed very well in this measure. In fiscal
1996 and fiscal 1997, the QUEST C-section rates were essentially
unchanged at about 11 percent (see Chart 4). This rate is far lower
than the NCQA’s national average of 20.6 percent, and the national
fee-for-service (FFS) rate of 29.1 percent. QUEST’s fiscal 1996 and
fiscal 1997 rates have actually exceeded the national health’s
established C-section rate of 12-15 percent by the year 2000.
Chart4
Diabetic Retinal Exam
Why is this important?
Diabetes mellitus affects about 6.5 percent of Hawaii’s popula
tion, and it is the leading cause of severe eye damage and adult
blindness in the United States. However, blindness can be prevented
if retinal changes are detected early, and treated appropriately with
laser. Therefore, early intervention through effective screening is
crucial in preserving the eye sight of individuals with diabetes.
What was measured?
This was an optional measure for QUEST plans. However, two of
the larger medical plans submitted data on this measure for fiscal
1997. The diabetic eye exam rate is the percentage of plan members
with diabetes aged 31 to 64 years who received an ophthalmoscopic
eye exam in fiscal 1997. Members in the plan must be enrolled
continuously during the reporting period (allowing for one break in
service, not to exceed 30 days).
How did QUEST perform?
In this measure, QUEST out-performed both the NCQA’s na
tional average and FFS rates (see Chart 5). The QUEST rate of 42.6
percent in fiscal 1997 indicates that the QUEST performance
compares favorably with that of managed care in the private sector.
QUEST plans did not report this measure in fiscal 1996.
Cesarean Section Rates
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Inpatient Acute Hospital Care
Why is this important?
Inpatient acute hospital care is one of the most costly expenses of
a health plan. It is a measure of a plan’s performance in managing
patient care.
What was measured?
The total number of QUEST enrollees who received inpatient
hospital care and the category of care they received (medical!
surgical; maternity; and newborns) by age were measured. The total
number of hospital days, days by category of care, and the average
length of stay (ALOS) were also reported.
How did QUEST perform?
Compared with the previous fiscal year, there were fewer total
days and fewer inpatient discharges. This was consistent with the
decrease in enrollment. However, the total ALOS and the ALOS for
each category of care remained essentially the same (see Chart 6).
The QUEST ALOS for total acute inpatients was 3.3 days in fiscal
1997. In contrast, the latest available statewide and national ALOS
reported by the Healthcare Association of Hawaii for acute care
hospitals in 1995 were 6.5 days and 5.7 days respectively.
Emergency Room Visits
Why is this important?
The emergency room rate is a critical measure of appropriate
utilization of health care because a visit to the emergency room is
largely member initiated, and emergency room costs for non-
emergency care are much higher than visits to PCPs. Historically,
the higher emergency room utilization of Medicaid populations
compared with the general public has been attributed to the inad
equate access by Medicaid enrollees to other primary care options.
By providing education to patients so that they will utilize emer
gency room services more appropriately and by improving access to
primary care, managed care plans should be able to bring down
emergency room rates.
What was measured?
This HEDIS measurement reports the total number of QUEST
emergency room visits which did not result in inpatient stays. Each
Source: Med-QUEST.
visit is counted once, regardless of the intensity of care required or
the length of time spent.
How did QUEST perform?
Compared with the previous fiscal year, QUEST showed im
provement. The total number of emergency room visits and the rate
of emergency room utilization had both decreased. In fiscal 1997,
the QUEST emergency room rate was 457.7 per 1,000 members.
This rate is higher than the last available 1995 rates of 305.2 per
1,000 population statewide and the national rate of 380 per 1,000
population. We believe the emergency room rate for QUEST will
decrease further in future as QUEST members become better
educated on appropriate use of emergency room services and how
to better access services through PCPs.
Live Births
Why is this important?
Medicaid has traditionally been a major payer for deliveries and
newborn care. In the late I 980s, the federal government encouraged
states to expand income eligibility for pregnant women and new
borns because of studies which demonstrated savings of at least $3
in direct care for each dollar spent on care given to pregnant women.
Thus, this HEDIS measure is important because it enumerates the
deliveries covered by QUEST and the general health of the new
borns after delivery.
Chart 5
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What was measured?
The total number of live births (including separate counts of well
newborns and complex newborns), the number of inpatient hospital
days, and the average length of stay for women of different ages
were reported.
How did QUEST perform?
The total number of QUEST deliveries resulting in live births
decreased from 4,916 in fiscal 1996 to 4,065 in fiscal 1997. How
ever, the average length of hospital stays for well newborns in
creased slightly from 1.44 days to 1.74 days, while that for complex
cases decreased from 16.46 days to 15.46 days. We feel that the
decrease in births can be explained by the decrease in QUEST
enrollment. The increase in average length of stay for well newborns
is consistent with the QUEST policy of allowing physicians and
families to determine how long a healthy newborn and mother
should remain in hospital.
What was measured?
The utilization of mental healthlchemical dependency services by
age and sex was measured. The services are grouped into the
following general categories—(l) members receiving any service;
(2) inpatient hospital services; (3) day/night services, and (4) ambu
latory services.
How did QUEST perform?
The actual number of mental health services provided decreased
9.6 percent between fiscal 1996 and fiscal 1997. Chart 8 shows the
decrease was less significant as a percentage of members receiving
services across the different categories ofservices. This is consistent
with the decrease in overall QUEST enrollment count of six (6)
percent. For chemical dependency services, the actual number of
services dropped four (4) percent but the percentage of members
who had received these services by different categories remained
essentially unchanged.
In addition to the decrease in QUEST membership, the following
factors should be considered in evaluating the decline in actual
number of mental health and chemical dependency services:
• CHF is the most frequent cause of
hospitalization for people 65 and older V
• 50% of ClIF patients die within 5 years
of diagnosis
Mental Health and Chemical Dependency
Services
Why is this important?
Utilization of mental health and chemical dependency services is
important because it is an indirect measure of a QUEST member’s
ability to access these services. Beyond that, it measures the ad
equacy of the provider network established by a QUEST plan to
provide appropriate mental health and chemical dependency ser
vices.
• The benefit package for mental health and chemical dependency
services was unlimited for the first eight (8) months of fiscal 1996
but limited to 30 inpatient hospital days and 24 hours ofoutpatient
services in fiscal 1997;
• One QUEST plan reported encounters for 11 months instead of 12
months for fiscal 1997, thus the actual number of services pro
vided should be higher;
congestive heart failure (CHF) starts with
the inability of the heart to pump out all
of the blood that returns to it. The result:
• From 1979 to 1993, CHF deaths
increased almost 110 percent
©1 997, American Heart Association
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• The processing of enrollment into the behavioral managed care
plan for the seriously mentally ill (SMI) adults improved. There
fore, mental health services used by QUEST members in most
need of mental health services were not being provided and
reported by the QUEST plans. Instead, these services were being
provided by the QUEST behavioral managed care plan for SMI
adults.
Outpatient Drug Utilization
Why is this important?
This measure assists health plans and the Department to assess
how cost effective the QUEST drug benefit is being administered.
What is being measured?
The total cost of prescription drugs, the average cost per member
per month, the total number of prescriptions filled, and the average
number of prescriptions filled per year for QUEST members of
different ages are measured.
How did QUEST perform?
The total costs of QUEST drug benefits decreased by more than
$6 million in fiscal 1997 compared with fiscal 1996. Cost per
member per month decreased by 13.6 percent from $13.92 to
$12.03. The total number and average number ofprescriptions filled
also decreased. Studies have shown that decreases in drug benefits,
if done inappropriately, may be accompanied by increases in emer
gency room visits, mental health services, and inpatient hospital
utilization. This did g.happen in the QUEST program and thus, we
feel the decreases in the drug benefit did gi affect access to care, nor
did it promote overutilization of more costly care. The inference is
that the imposition of managed care provided needed control on
drug utilization without denying access.
Low Birthweight
Why is this important?
In the United States, 263,000 low birthweight infants (weight less
than 2,500 grams) are born annually. Low birthweight infants face
higher risk for chronic and permanent disabilities, serious medical
complications and illnesses, and death in infancy. Low-income
women are typically at higher risk for having low birthweight
infants. There are many factors which increase a woman’s risk of
having a low birthweight infant. Some of the more common factors
$14.00
$13.50
$13.00
$12.50
$12.00
$11.50
$11.00
Source: Med-QUEST.
Chart9
Outpatient Drug Utilization
include smoking, poor nutrition, and chronic medical conditions. It
is widely felt by the medical profession that the incidence of low
birthweight can be decreased by improving access to appropriate
prenatal care.
What was measured?
The percentage of low birthweight (less than 2,500 grams) infants
born during the fiscal year was measured using hospital discharge
data or birth certificate data.
How did QUEST perform?
Although the number of low birthweight babies crept up slightly
from fiscal 1996 to fiscal 1997, the QUEST rate is still very good and
do not indicate that QUEST pregnant women have a higher rate of
low birthweight infants compared to their peers in the state. Chart 10
shows that QUEST’s low birthweight rate of 5.8 percent in fiscal
1997 is lower than the overall state’s rate of 6.7 percent in 1996. We
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believe QUEST is doing well in this measure and will continue to do
so in the future with better monitoring and pre-natal care for
members.
The QUEST low birthweight rate of 5.3% in fiscal 1996 was
actually better than Kaiser Permanente Hawaii’s commercial plan
rate of 5.4 percent’ in calendar year 1996.
Kaiser Permanente Hawaii is ranked as one of the best managed care
plans in the United States.
Chart 10
How did QUEST perform?
In fiscal 1997, the utilization of PCPs by QUEST children
continued to improve. In fiscal 1996, QUEST’s rates for the differ
ent age categories exceeded 80 percent. The average utilization rate
for all three age categories was about 83 percent (see Chart 11). In
fiscal 1997, rates for the different age categories jumped to the high
80s and the average utilization for all three age groups jumped to 90
percent. The inference here is that QUEST children have excellent
access to their PCPs.
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Care Access: Utilization of Primary Care
Providers by Children
Why is this important?
Traditionally, under the fee-for-service Medicaid Program, ac
cess to non-emergency care was difficult to obtain. One of the
primary reasons Hawaii turned to managed care was to improve
access to non-urgent, preventive care. By requiring that each
QUEST member have his/her own primary care provider (PCP), the
State felt that access to medical care and the general health of
Medicaid recipients would be improved. Children comprise about
56 percent of total QUEST membership. Therefore, children’s
utilization of primary care services through PCPs is an important
measure of access.
What was measured?
The rates of utilization of primary care providers by children are
the rates of QUEST children enrolled in one plan for 12 months by
the following age categories:
• children aged 12 to 24 months who had at least one visit to a
primary care provider (PCP) during the past 12 months;
• children 25 months to 6 years who had at least one visit to a
primary care provider (PCP) during the past 12 months: and
• children aged 7 years to Il years, enrolled in one plan for two
years, who had at least one visit to a PCP in the past 12 to 24
months.
See Kaiser Perrnanente Hawaii’s 1997 Quality Report (page 11). Kaiser Permanente Hawaii recently
received a tour.star rating, and was ranked as the sixth best plan in the U.S. News & Wodd Report’s annual
appraisal ot ‘Amedca S Top HMOs.”
•12-24 Mth.
025 Mth-6 Yr.
7-11 Yr.
Managed Care in Hawaii QUEST
In fiscal 1997, QUEST eligible persons were able to choose from
five (5) QUEST medical plans. These QUEST plans are unique with
five (5) different approaches to the delivery of medical care and five
(5) different structures and organizational experiences. A summary
description of the QUEST medical plans is as follows:
• AlohaCare is a plan formed by community health centers, and
QUEST is its single line of business;
• HMSA-OUEST is a plan by a local, non-profit, mutual benefit
society associated with Blue Cross/Blue Shield — with many
commercial lines of business;
• Kaiser Permanente OUEST is a plan by a large, nationally
affiliated, non-profit Health Maintenance Organization (HMO);
• Oueen’s Hawaii Care is a plan by a local, non-profit health care
system; and
• Straub Care Ouantum is a plan by a local, for-profit health care
system.
Kaiser Permanente QUEST and Straub Care Quantum can be
described as “closed panel” health plans because the care they
provide is largely performed by their staff physicians in their own
clinics and facilities. AlohaCare, HMSA-QUEST, and Queen’s
Hawaii Care are “open panel” health plans which contract with
health care providers to provide care at various sites, largely, the
providers’ offices and facilities.
Although each QUEST health plan operates differently, all of the
plans utilize managed care concepts in the provision of health care
to QUEST members. Four (4) key components which are critical to
the delivery of care in managed care and how these programs are
used by QUEST health plans will be briefly described.
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Case Management
What is it?
Case Management is a process to identify and
assist members with complex or chronic condi
tions. This includes helping members who have
difficulties in obtaining needed medical care to
gain access and to obtain the appropriate care.
How do QUEST plans perform case manage
ment?
All of the plans have systems which identify
members who may need case management/care
coordination. Although plans are free to deter
mine which recipients need case management,
generally, plans priorities for case management
are similar, and include high risk pregnancies,
lengthy hospitalizations, and chronic diseases
such as asthma or diabetes.
The two closed panel plans perform case man
agement services using plan staff. The three
open panel plans also perform most case man
agement activities using plan staff. In addition,
AlohaCare uses case management services of
the community health centers. HMSA-QUEST
contracts with the community health centers and
other community agencies for specific outreach
services such as transportation, translation and
non-compliance counseling. Queen’s Hawaii
Care has contracted for patient education and
case management to assist providers on a neigh
bor island in an Asthma Management Program.
Utilization Management
What is it?
Utilization management is the process which
plans use to determine the appropriateness and
need for medical care. Plans evaluate utilization
patterns (including under-utilization and over-
utilization) through data analysis and provider
profiling. Among the specific programs used to
make decisions of appropriateness and need are
prior authorization, concurrent review, and ret
rospective review.
EDWARD W. Ko, MBA, CPA
Thx Oriented Strategies & Innovative AlfernatiEres
941-1818
Tax Exempt VEBA mist
The powerful 70-year-old tax strategy custom-designed perfectly
for todays Ultimate Employee
- the medical practit)oner.
• Pension Fund Access Program
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allows pension fund buildup liquidation without the usual b)g tax bite,
How do QUEST plans perform utilization
management?
Although plans differ in the specific services!
situations which require prior authorization, all
plans utilize prior authorization in some form.
For inpatient hospital, concurrent and retrospec
tive reviews, all five (5) plans employ
Chart 12
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New Member OrientationfEducation
What is it?
New member orientation/education are the activities performed
by plans to educate and orient new members on the types of covered
services and how to access those care services.
How do QUEST plans do this?
All QUEST plans send welcome packets of information including
a member handbook, list of providers, summary of plan benefits,
how a member can access care, and member rights and responsibili
ties. In addition, HMSA-QUEST conducts optional member orien
tation sessions; Kaiser Permanente QUEST has case management
assistants and visiting nurses who work directly with new enrollees;
Straub Care Quantum includes in its welcome packet the (800)
number of its HMO Services personnel who can answer questions
and assist members in obtaining services; Queen’s Hawaii Care
issues quarterly member newsletters which features educational
material as well as updated plan member services; AlohaCare uses
its Member Services department to reinforce the programs in the
Member Handbook. Also, all plans send out Early and Periodic
Screening, Diagnosis and Treatment (EPSDT) information. (Under
Federal EPSDT rules children are entitled to a broader range of
Medicaid services than adults and it is required that parents receive
information explaining EPSDT benefits).
Standards for Waiting Times
What are these?
Each plan sets its own standards for acceptable waiting times for
the following:
1. Emergency care;
2. Urgent routine illness; and
3. Preventive and non-urgent routine care.
What are the standards used by the plans and how are they being
monitored?
Although each plan sets its own standards for waiting times, all
plans are generally in agreement that the standard waiting time are
as follows:
1. Emergency care is immediately (within the same day);
2. Urgent routine illness is from 24 to 48 hours; and
3. Preventive and non-urgent routine care is from 24-48 hours
to 6 weeks.
Plans monitor these standards by on-site visits to providers
(Queen’s Hawaii Care and HMSA-QUEST), member surveys
and appointment accessibility surveys (HMSA-QUEST), waiting
time surveys (Straub Care Quantum), actual measurements (Kai
ser Permanente QUEST), and member education on appropriate
use of services (AlohaCare).
Quest Capitation History
When QUEST was initiated in August 1994, the premium savings
associated with each enrolled member was approximately 6.4 per
cent lower than payments under the previous fee-for-service system.
Chart 12 shows that more premium savings have been realized
subsequently in fiscal 1996, fiscal 1997 and fiscal 1998, without
compromising quality health care services to the QUEST popula
tion. Selected clinical measures reported under HEDIS guidelines
have supported this contention. We believe much of the success is
attributable to productivity gains and continuous quality improve
ments in both clinical and administrative areas of participating
QUEST plans.
Towards the Millenium
The member’s freedom to choose a health plan has always been
an important consideration in QUEST. As participating QUEST
plans continue to mature in utilizing managed care concepts in the
provision of services to the Medicaid population, they are continu
ously driven to improving and upgrading their services. The plans
are fully aware of their similar product offerings, and that quality of
service is the key determinant to winning consumer confidence.
QUEST members are the primary beneficiaries of this competitive
structure established by the State. The DHS, through its Med
QUEST Division will continue in its efforts to monitor the quality
of services offered by participating plans. The MQD is also explor
ing innovative ways to improve the delivery of health care services
to the Medicaid population in Hawaii, currently not in QUEST.
As we move closer to the millennium, QUEST is working dili
gently to extend managed care services to more Medicaid recipients.
We believe that managed care can effectively deliver to the Medic
aid population, greater access to non-urgent and preventive health
care services, and improvement in their general health status. The
offering of long-term care services through a managed care setting
is currently under consideration. Certain segments of Hawaii’s
community view this as a viable, “high-value” alternative to the
existing fee-for-service system. With each existing, and potential
service offering, consumer protection will continue to remain a key
pillar of QUEST’s efforts. And towards achieving this goal, QUEST
will continue to use HEDIS measures to define quality of care
services in a tangible, quantitative, and meaningful manner.
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